Pharmacokinetics of iodine-123-IMBA for melanoma imaging.

Abstract

Due to rapid background clearance and high melanoma affinity, IMBA showed high tumor contrast already at 4 hr after injection which makes it a promising new radiopharmaceutical for the scintigraphic detection of melanoma metastases.